Abstract
BackgroundUterine serous carcinoma is a distinct histologic subtype of endometrial cancer with an aggressive phenotype, poor prognosis, and limited therapeutic options. A previous proof-of-concept phase II trial of the Wee1...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have